Iridex Share Price Today
(NASDAQ: IRIX)

Name: Iridex Share Price Today (NASDAQ: IRIX) - Iridex Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Iridex share price is $1.29 & ₹112.19 as on 6 Mar 2025, 2.30 'hrs' IST

$1.29

▲

0.05

(4.03%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Iridex share price in Dollar and Rupees. Guide to invest in Iridex stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iridex, along with analyst recommendations, forecasts, and comprehensive financials.

Iridex share price movements

Today's Low: $1.23
Today's High: $1.38
$1.29
4.65%
Downside
Day's Volatility :10.87%
Upside
6.52%
52 Weeks Low: $1.23
52 Weeks High: $3.65
$1.29
4.65%
Downside
52 Weeks Volatility :66.3%
Upside
64.66%

Iridex (IRIX) Returns

Period	Iridex Corp	Index (Russel 2000)
3 Months	-25.43%	0.0%
6 Months	-35.82%	0.0%
1 Year	-50.0%	0.0%
3 Years	-69.65%	-11.6%

Iridex (IRIX) Key Statistics

in dollars & INR

Previous Close	$1.24
Open	$1.23
Today's High	$1.38
Today's Low	$1.23
Market Capitalization	$27.6M
Today's Volume	$11.5K
52 Week High	$3.65
52 Week Low	$1.23
Revenue TTM	$48.4M
EBITDA	$-10.1M
Earnings Per Share (EPS)	$-0.67
Profit Margin	-22.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-150.28%

How to invest in Iridex Stock (IRIX) from India?

It is very easy for Indian residents to invest directly in Iridex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iridex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iridex or IRIX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iridex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iridex shares which would translate to 0.674 fractional shares of Iridex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iridex, in just a few clicks!

Returns in Iridex (IRIX) for Indian investors in Rupees

The Iridex stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Iridex investment value today

Current value as on today

₹54,949

Returns

₹45,051

(-45.05%)

Returns from Iridex Stock

₹50,000 (-50%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Iridex (IRIX)

-44%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Iridex Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Iridex

PARAGON Assoc & PARAGON Assoc II JV
6.01%
Vanguard Group Inc
3.37%
AMH Equity Ltd
3.01%
Renaissance Technologies Corp
2.29%
Geode Capital Management, LLC
0.79%
Schmeidler A R & CO Inc
0.66%

Analyst Recommendation on Iridex

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Iridex(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iridex Stock (IRIX)

What analysts predicted

Upside of 55.04%

Target:

$2.00

Current:

$1.29

Insights on Iridex Stock (Ticker Symbol: IRIX)

Price Movement
In the last 7 days, IRIX stock has moved down by -10.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 12.63M → 11.58M (in $), with an average decrease of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -3.46M → -1.93M (in $), with an average increase of 34.0% per quarter
IRIX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 105.3%
IRIX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 208.5%
Price to Sales
ForIRIX every $1 of sales, investors are willing to pay $0.4, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

IRIX Iridex Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$42.6M	↑ 2.42%
Net Income	$-12.8M	↓ 0.42%
Net Profit Margin	-30.08%	↑ 0.86%

	FY19	Y/Y Change
Revenue	$43.4M	↑ 1.99%
Net Income	$-8.8M	↓ 31.22%
Net Profit Margin	-20.28%	↑ 9.8%

	FY20	Y/Y Change
Revenue	$36.3M	↓ 16.34%
Net Income	$-6.3M	↓ 28.19%
Net Profit Margin	-17.41%	↑ 2.87%

	FY21	Y/Y Change
Revenue	$53.9M	↑ 48.3%
Net Income	$-5.2M	↓ 17.44%
Net Profit Margin	-9.69%	↑ 7.72%

	FY22	Y/Y Change
Revenue	$57.0M	↑ 5.69%
Net Income	$-7.5M	↑ 44.44%
Net Profit Margin	-13.25%	↓ 3.56%

	FY23	Y/Y Change
Revenue	$51.9M	↓ 8.96%
Net Income	$-9.6M	↑ 26.81%
Net Profit Margin	-18.45%	↓ 5.2%

	Q2 FY23	Q/Q Change
Revenue	$12.9M	↓ 6.21%
Net Income	$-2.8M	↑ 32.34%
Net Profit Margin	-21.52%	↓ 6.27%

	Q3 FY23	Q/Q Change
Revenue	$12.9M	↓ 0.04%
Net Income	$-1.8M	↓ 36.59%
Net Profit Margin	-13.65%	↑ 7.87%

	Q4 FY23	Q/Q Change
Revenue	$12.5M	↓ 3.05%
Net Income	$-3.0M	↑ 68.76%
Net Profit Margin	-23.76%	↓ 10.11%

	Q1 FY24	Q/Q Change
Revenue	$11.8M	↓ 5.59%
Net Income	$-3.5M	↑ 17.03%
Net Profit Margin	-29.45%	↓ 5.69%

	Q2 FY24	Q/Q Change
Revenue	$12.6M	↑ 7.4%
Net Income	$-2.7M	↓ 22.66%
Net Profit Margin	-21.21%	↑ 8.24%

	Q3 FY24	Q/Q Change
Revenue	$11.6M	↓ 8.31%
Net Income	$-1.9M	↓ 27.85%
Net Profit Margin	-16.69%	↑ 4.52%

	FY18	Y/Y Change
Profit	$17.5M	↑ 12.69%

	FY19	Y/Y Change
Profit	$17.9M	↑ 2.68%

	FY20	Y/Y Change
Profit	$15.6M	↓ 13.27%

	FY21	Y/Y Change
Profit	$22.8M	↑ 46.75%

	FY22	Y/Y Change
Profit	$25.4M	↑ 11.11%

	FY23	Y/Y Change
Profit	$21.8M	↓ 14.04%

	Q2 FY23	Q/Q Change
Profit	$5.4M	↓ 9.68%

	Q3 FY23	Q/Q Change
Profit	$5.6M	↑ 4.81%

	Q4 FY23	Q/Q Change
Profit	$4.8M	↓ 14.55%

	Q1 FY24	Q/Q Change
Profit	$4.4M	↓ 8.93%

	Q2 FY24	Q/Q Change
Profit	$5.1M	↑ 15.5%

	Q3 FY24	Q/Q Change
Profit	$4.3M	↓ 14.43%

	FY18	Y/Y Change
Operating Cash Flow	$-10.0M	↑ 181.21%
Investing Cash Flow	$-827.0K	↑ 5.75%
Financing Cash Flow	$10.4M	↑ 349.89%

	FY19	Y/Y Change
Operating Cash Flow	$-7.9M	↓ 21.07%
Investing Cash Flow	$-509.0K	↓ 38.45%
Financing Cash Flow	$-156.0K	↓ 101.5%

	FY20	Y/Y Change
Operating Cash Flow	$-3.2M	↓ 59.09%
Investing Cash Flow	$-93.0K	↓ 81.73%
Financing Cash Flow	$2.5M	↓ 1681.41%

	FY21	Y/Y Change
Operating Cash Flow	$8.2M	↓ 353.85%
Investing Cash Flow	$-5.6M	↑ 5874.19%
Financing Cash Flow	$9.5M	↑ 283.7%

	FY22	Y/Y Change
Operating Cash Flow	$-9.5M	↓ 215.85%
Investing Cash Flow	$-286.0K	↓ 94.85%
Financing Cash Flow	$-73.0K	↓ 100.77%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 59.87%
Investing Cash Flow	$-16.0K	↓ 62.79%
Financing Cash Flow	$-63.0K	↓ 270.27%

Iridex Technicals Summary

Sell

Neutral

Buy

Iridex is currently in a neutral trading position according to technical analysis indicators.

Iridex (IRIX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iridex Corp	-21.51%	-35.82%	-50.0%	-69.65%	-39.15%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iridex Corp	NA	NA	-0.44	0.0	-1.5	-0.21	NA	0.16
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iridex Corp	Sell	$27.6M	-39.15%	NA	-22.79%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Iridex

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Organization	Iridex
Employees	111
CEO	Mr. Patrick Mercer
Industry	Health Technology

Management People of Iridex

Name	Title
Mr. Scott A. Shuda J.D.	Executive Chairman
Mr. Patrick Mercer	CEO, President & Director
Mr. Fuad Ahmad	Interim Chief Financial Officer
Ms. Leigh Salvo	Head of Investor Relations

Important FAQs about investing in IRIX Stock from India :

What is Iridex share price today?

Iridex share price today stands at $1.29, Open: $1.23 ; Previous Close: $1.24 ; High: $1.38 ; Low: $1.23 ; 52 Week High: $3.65 ; 52 Week Low: $1.23.

The stock opens at $1.23, after a previous close of $1.24. The stock reached a daily high of $1.38 and a low of $1.23, with a 52-week high of $3.65 and a 52-week low of $1.23.

Can Indians buy Iridex shares?

Yes, Indians can invest in the Iridex (IRIX) from India.

With INDmoney, you can buy Iridex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iridex at zero transaction cost.

How can I buy Iridex shares from India?

It is very easy to buy Iridex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iridex (IRIX) be purchased?

Yes, you can buy fractional shares of Iridex with INDmoney app.

What are the documents required to start investing in Iridex stocks?

To start investing in Iridex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.